Back to search

Massachusetts Institute of Technology

Long range planning of biologics process development and clinical trial material supply process

Abstract

dc:description.abstract

This thesis investigates the feasibility of using a complex model with a Monte Carlo simulation model to forecast the financial, personnel, and manufacturing capacity resources needed for biologic drug development. Accurate forecasting is integral across industries in order to make strong longterm, strategic decisions and an area many companies struggle with. The resources required for the development of a biologic drug are especially hard to estimate due to the variability in the time and probability of success of each development phase. However, in the pharmaceutical industry getting products to market faster allows the company more time to recoup the substantial development investments before the patent expires and also potentially has a large impact on a company's market share. For these reasons, Novartis Biologics wanted to develop a simulation model to provide an objective opinion and assist them in their long-range planning. This thesis describes the design, development, and functionalities of the resultant model. During validation runs, the model demonstrated accuracy of greater than 90% when compared against historical data for headcount, number of campaigns, costs, and projects per year. In addition, the model contains Monte Carlo simulation capabilities to allow users to forecast variability and test the sensitivity of the results. This proves the model can be confidently used by project management, operations, and finance to predict their respective future resource needs.

Degree

thesis:*
Department dc:contributor.department
Leaders for Global Operations Program at MIT
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2011

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Edwards, Emily (Emily Rose)
Advisor dc:contributor.advisor
  • Roy Welsch and Charles Cooney.

Subjects

dc:subject × 3

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/66068
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/66068

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Edwards, Emily (Emily Rose). Long range planning of biologics process development and clinical trial material supply process. Massachusetts Institute of Technology, 2011. http://hdl.handle.net/1721.1/66068